12.01
-0.08 (-0.66%)
-0.08 (-0.66%)
Upgrade to Real-Time
Regular Market
Low
9.21
High
15.69
Best deals to access real time data! |
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Innoviva Inc | INVA | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -0.08 | -0.66% | 12.01 | 11:03:04 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 12.14 | 11.949 | 12.21 | 12.09 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 12.00 | 12.03 | 0.03 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 444 | 37,423 | $ 12.08 | $ 452,161 | 700,063 | 9.21 - 15.69 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 11:02:55 | 100 | $ 12.01 | USD |
Innoviva Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 1.22B | 101.39M | 57.64M | $ 261.02M | $ 231.86M | 1.43 | 6.30 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Innoviva News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical INVA Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 11.85 | 12.21 | 11.62 | 11.95 | 297,093 | 0.16 | 1.35% |
| 1 Month | 11.60 | 12.86 | 11.39 | 11.94 | 462,633 | 0.41 | 3.53% |
| 3 Months | 12.23 | 12.90 | 10.92 | 11.90 | 542,443 | -0.22 | -1.8% |
| 6 Months | 9.73 | 13.06 | 9.21 | 11.53 | 616,598 | 2.28 | 23.43% |
| 1 Year | 13.33 | 15.69 | 9.21 | 12.24 | 655,888 | -1.32 | -9.9% |
| 3 Years | 16.10 | 20.54 | 7.58 | 13.72 | 750,916 | -4.09 | -25.4% |
| 5 Years | 13.70 | 20.54 | 7.58 | 13.34 | 794,078 | -1.69 | -12.34% |
Innoviva Description
| Innoviva Inc develops biopharmaceutical drugs in the antibiotic, respiratory, and digestive realms. Theravance's respiratory compounds are in late-stage trials for asthma and chronic obstructive pulmonary disease. Its product offering includes RELVAR/BREO/ELLIPTA, ANORO, ELLIPTA, TRELEGY, ELLIPTA, and others. The firm collaborates with and receives funding from GlaxoSmithKline. |
